Результаты клинических исследований препарата «Тантум Верде

ɩɚɪɨɞɨɧɬɟ. / Ⱥɤɬɭɚɥɶɧɵɟ ɜɨɩɪɨɫɵ ɫɬɨɦɚɬɨɥɨɝɢɢ:
ɬɟɡɢɫɵ ɞɨɤɥ. ȼɫɟɪɨɫ. ɇɚɭɱ.-ɩɪɚɤɬ. Ʉɨɧɮ. Ɇɨɫɤɜɚ
2000, ɫ. 78-79.
8.
Ʉɪɟɝɢɧɚ ȿ.Ʉ. Ɉɩɪɟɞɟɥɟɧɢɟ ɫɬɟɩɟɧɢ ɦɢɤɪɨɰɢɪɤɭɥɹɰɢɢ ɧɚɪɭɲɟɧɢɣ ɜ ɩɚɪɨɞɨɧɬɟ ɦɟɬɨɞɨɦ ɥɚɡɟɪɧɨɣ ɞɨɩɩɥɟɪɨɜɫɤɨɣ ɮɥɨɭɦɟɬɪɢɢ. // Ɇɟɬɨɞɵ ɢɫɫɥɟɞɨɜɚɧɢɹ ɪɟɝɢɨɧɚɥɶɧɨɝɨ ɤɪɨɜɨɨɛɪɚɳɟɧɢɹ – ɋɚɧɤɬɉɟɬɟɪɛɭɪɝ 2004, ɫ. 72-74.
9.
Ʌɨɝɢɧɨɜɚ ɇ.Ʉ. Ʉɪɢɬɟɪɢɢ ɢ ɦɨɪɮɨɮɭɧɤɰɢɨɧɚɥɶɧɵɟ ɦɟɬɨɞɵ ɨɰɟɧɤɢ ɤɪɨɜɨɨɛɪɚɳɟɧɢɹ. // ɋɛ. ɧɚɭɱ.
Ɋɚɛɨɬ: ɆɆɋɂ – Ɇɨɫɤɜɚ 1997, ɫ. 248-249.
10.
əɤɭɧɨɜ Ɋ.ɒ., Ʉɨɩɟɣɤɢɧ ȼ.ɇ., Ɍɟɥɶɦɚɧ ɋ.Ȼ.
Ƚɟɦɨɞɢɧɚɦɢɤɚ ɩɚɪɨɞɨɧɬɚ ɨɩɨɪɧɵɯ ɡɭɛɨɜ ɩɪɢ ɩɪɢɦɟɧɟɧɢɢ ɧɟɫɴɟɦɧɵɯ ɦɨɫɬɨɜɢɞɧɵɯ ɩɪɨɬɟɡɨɜ. // ɉɪɨɮɢɥɚɤɬɢɤɚ ɢ ɥɟɱɟɧɢɟ ɡɭɛɨɱɟɥɸɫɬɧɵɯ ɚɧɨɦɚɥɢɣ. ɍɮɚ,
1989, ɫ. 64-65.
11.
Ʉɨɪɨɥɟɜ ɋ.Ʌ. Ʉɥɢɧɢɤɨ-ɮɭɧɤɰɢɨɧɚɥɶɧɚɹ
ɯɚɪɚɤɬɟɪɢɫɬɢɤɚ ɩɚɬɨɥɨɝɢɱɟɫɤɢɯ ɫɨɫɬɨɹɧɢɣ ɩɚɪɨɞɨɧɬɚ
ɢ ɢɯ ɜɥɢɹɧɢɟ ɧɚ ɪɟɡɟɪɜɧɵɟ ɜɨɡɦɨɠɧɨɫɬɢ ɨɩɨɪɧɵɯ
ɡɭɛɨɜ. Ⱦɢɫɫ. ɤɚɧɞ. ɦɟɞ. ɇɚɭɤ. Ɇɨɫɤɜɚ 2006.
12.
Ɇɢɬɪɨɧɢɧ ȼ.Ⱥ. ɉɪɨɝɧɨɡɢɪɨɜɚɧɢɟ ɮɭɧɤɰɢɨɧɚɥɶɧɨɣ ɫɨɫɬɨɹɬɟɥɶɧɨɫɬɢ ɨɩɨɪɧɵɯ ɡɭɛɨɜ ɩɪɢ
ɨɪɬɨɩɟɞɢɱɟɫɤɨɦ ɥɟɱɟɧɢɢ. Ⱥɜɬɨɪɟɮ. Ⱦɢɫɫ. ɦɟɞ. ɇɚɭɤ,
Ɇɨɫɤɜɚ 2011.
13.
ȿɪɦɨɥɨɜ ȼ.ȼ. ɅȺɡɟɪɧɚɹ ɩɪɨɮɢɥɚɤɬɢɤɚ
ɩɚɪɨɞɨɧɬɚɥɶɧɵɯ ɨɫɥɨɠɧɟɧɢɣ ɩɪɢ ɨɪɬɨɩɟɞɢɱɟɫɤɨɦ
ɥɟɱɟɧɢɢ ɧɟɫɴɟɦɧɵɦɢ ɩɪɨɬɟɡɚɦɢ. Ⱥɜɬɨɪɟɮ. Ⱦɢɫɫ.
ɤɚɧɞ. ɦɟɞ. ɧɚɭɤ, Ɇɨɫɤɜɚ 2004.
14.
ȼɚɧɹɧ ɇ.Ƚ., Ɍɚɬɢɧɰɹɧ Ʌ.ȼ., ȿɫɚɹɧ Ʌ.Ʉ.,
ɒɚɝɢɧɹɧ Ⱥ.ɝ., Ⱥɜɟɬɢɫɹɧ Ⱥ.Ⱥ. ȼɥɢɹɧɢɟ ɧɟɫɴɟɦɧɵɯ
ɦɟɬɚɥɥɢɱɟɫɤɢɯ ɩɪɨɬɟɡɨɜ ɜ ɩɨɥɨɫɬɢ ɪɬɚ ɧɚ ɫɨɫɬɨɹɧɢɟ
ɡɭɛɨɜ ɢ ɬɤɚɧɟɣ ɩɚɪɨɞɨɧɬɚ // Ɇɟɞɢɰɢɧɚ, ɧɚɭɤɚ ɢ
ɨɛɪɚɡɨɜɚɧɢɟ, ȿɪɟɜɚɧ 2009 / 2, ɫ. 78-81.
15.
Ɍɚɬɢɧɰɹɧ Ʌ.ȼ., ȿɫɚɹɧ Ʌ.Ʉ., ȼɚɧɹɧ ɇ.Ƚ. Ʉ
ɜɨɩɪɨɫɭ ɢɡɭɱɟɧɢɹ ɫɨɫɬɨɹɧɢɹ ɩɭɥɶɩɵ ɢ ɩɟɪɢɨɞɨɧɬɚ
ɩɪɢ ɩɪɨɬɟɡɢɪɨɜɚɧɢɢ ɡɭɛɨɜ ɪɚɡɥɢɱɧɵɦɢ ɨɪɬɨɩɟɞɢɱɟɫɤɢɦɢ ɤɨɧɫɬɪɭɤɰɢɹɦɢ // Ɇɚɬɟɪɢɚɥɵ ɤɨɧɮɟɪɟɧɰɢɢ ȿɪȽɆɍ, ȿɪɟɜɚɧ 2007 / ɫ. 165-166.
²Ýß³ñŠϳÙñç³Ó¨ åñáû½Ý»ñÇ ÏÇñ³éÙ³Ý
Å³Ù³Ý³Ï Ñ»Ý³Ï»ï³ÛÇÝ ³ï³ÙÝ»ñÇ å³ñá¹áÝïÇ
Ù³ñ·ÇÝ³É ÉÝ¹Ç ÙÇÏñáßñç³Ý³éáõÃÛ³Ý íÇ׳ÏÁ
Æ.².Ü»ñëÇëÛ³Ý
Ø»ñ ÏáÕÙÇó ϳï³ñí³Í Ù»ï³Õ³Ï»ñ³ÙÇÏ³Ï³Ý ÏáÝëïñáõÏódzݻñÇ ÙÇçáóáí ³ï³Ùݳ߳ñÇ Ù³ëݳÏÇ Ã»ñáõÃÛáõÝÝ»ñÇ ûñÃá廹ÇÏ
áõÅÙ³Ý Ñ»ï³½áïáõÃÛáõÝÝ»ñÁ ÑÇÙù »Ý ѳݹÇë³ÝáõÙ ³ï³ÙÝ»ñÇ Ñ»Ý³Ï»ï³ÛÇÝ ÑÛáõëí³ÍùÝ»ñÇ
ÙÇÏñáßñç³Ý³éáõÃÛ³Ý
íÇ׳ÏÇ
å³ñï³¹Çñ
³ßËÙ³Ý Ñ³Ù³ñ:
ØÇÝ㨠³Ýß³ñŠϳÙñç³Ó¨ åñáû½Ç ýÇùëáõÙÁ
ûñÃá廹ÇÏ áõÅÙ³Ý ÷áõÉ»ñáõÙ ¨ ѻﳽáïáõÃÛáõÝÝ»ñÇ Ñ»é³íáñ ųÙÏ»ïÝ»ñáõ٠ɳ½»ñ³-¹áåÉ»ñ³ÛÇÝ ýÉááõÙ»ïñdzÛÇ (ȸü) ïíÛ³É Ñ»ï³½áïáõÃÛáõÝÝ»ñÁ óáõÛó »Ý ï³ÉÇë, áñ ѻݳϻï³ÛÇÝ
³ï³ÙÝ»ñÇ Ù³ñ·ÇÝ³É Éݹ»ñÇ å³ñá¹áÝïÇ ÑÛáõëí³ÍùÝ»ñáõÙ ÙÇÏñáßñç³Ý³éáõÃÛ³Ý Ñ³Ù³Ï³ñ·Ç
ýáõÝÏóÇáÝ³É íÇ׳ÏÇ ûÛ»ÏïÇí ·Ý³Ñ³ï³Ï³ÝÁ
³ñ¹Ç³Ï³Ý ¿ ѳݹÇë³ÝáõÙ ³ï³Ùݳ߳ñ»ñÇ ¨
Ñ»é³íáñ ³ñ¹ÛáõÝùÝ»ñÇ Ï³ÝËáñáßÙ³Ý Ñ³Ù³ñ:
The state of microcirculation of marginal gingiva of
periodontal abutments in the application of nonremovable teeth bridges.
Nersisyan I.A.
Started our study of orthopedic treatment of partial
denture defect metal-ceramic structures dig basis for
determining the state of microcirculation of mandatory
supporting tissues of the teeth.
The studies of laser-Doppler flowmetry (LDF) in
steps of orthopedic treatment before fixing a nonremovable bridgelike prothesis and through long-term
observations show an objective assessment of the
functional state of the system micro-circulation in the
periodontal tissues of the marginal gingival of abutment
is relevant for predicting the near and long-term results of
prosthetics partial defects of denture.
Ɋɟɡɭɥɶɬɚɬɵ ɤɥɢɧɢɱɟɫɤɢɯ ɢɫɫɥɟɞɨɜɚɧɢɣ
ɩɪɟɩɚɪɚɬɚ «Ɍɚɧɬɭɦ ȼɟɪɞɟ» ɜ
ɬɟɪɚɩɟɜɬɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ
Ɍɚɬɢɧɰɹɧ ȼ.Ƚ.
ȿɪȽɆɍ ɢɦ. Ɇ. Ƚɟɪɚɰɢ, ɤɚɮɟɞɪɚ Ɍɟɪɚɩɟɜɬɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ,
ɈɈɈ “Ʉɜɚɧɬɭɦ ɋ”, “CSC LTD”
Ʉɥɸɱɟɜɵɜ ɫɥɨɜɚ: ɩɪɟɩɚɪɚɬ Ɍɚɧɬɭɦ ȼɟɪɞɟ, ɜɢɪɭɫɧɵɣ, ɝɪɢɛɤɨɜɵɣ ɫɬɨɦɚɬɢɬɵ, ɝɢɧɝɢɜɨɫɬɨɦɚɬɢɬ,
ɡɚɛɨɥɟɜɚɧɢɟ ɩɚɪɨɞɨɧɬɚ.
ɉɨɥɨɫɬɶ ɪɬɚ ɩɪɟɞɫɬɚɜɥɹɟɬ ɫɨɛɨɣ ɧɚɱɚɥɶɧɵɣ
ɨɬɞɟɥ ɠɟɥɭɞɨɱɧɨ-ɤɢɲɟɱɧɨɝɨ ɬɪɚɤɬɚ, ɚ ɟɟ ɫɥɢɡɢɫɬɚɹ ɨɛɨɥɨɱɤɚ ɨɫɭɳɟɫɬɜɥɹɟɬ ɬɚɤɢɟ ɮɭɧɤɰɢɢ, ɤɚɤ
ɩɢɳɟɜɚɪɟɧɢɟ, ɜɫɚɫɵɜɚɧɢɟ, ɢ, ɱɬɨ ɫɚɦɨɟ ɜɚɠɧɨɟ,
ɡɚɳɢɬɧɭɸ ɢ ɛɚɪɶɟɪɧɭɸ ɮɭɧɤɰɢɢ - ɡɚɳɢɬɭ ɨɬ
ɜɪɟɞɨɧɨɫɧɵɯ ɮɚɤɬɨɪɨɜ. ɇɚ ɩɪɨɬɹɠɟɧɢɢ ɜɫɟɣ
ɠɢɡɧɢ ɨɪɝɚɧɢɡɦɚ ɫɥɢɡɢɫɬɚɹ ɨɛɨɥɨɱɤɚ ɩɨɥɨɫɬɢ
ɪɬɚ (ɋɈɉɊ) ɩɨɞɜɟɪɝɚɟɬɫɹ ɜɨɡɞɟɣɫɬɜɢɹɦ ɪɚɡɥɢɱɧɵɯ ɪɚɡɞɪɚɠɚɸɳɢɯ ɮɚɤɬɨɪɨɜ. Ⱥɞɚɩɬɚɰɢɨɧɧɵɟ ɜɨɡɦɨɠɧɨɫɬɢ ɫɥɢɡɢɫɬɨɣ ɨɛɨɥɨɱɤɢ ɩɨɥɨɫɬɢ
39
ɪɬɚ ɨɝɪɨɦɧɵ, ɚ ɚɧɚɬɨɦɨ-ɮɢɡɢɨɥɨɝɢɱɟɫɤɨɟ ɫɬɪɨɟɧɢɟ ɭɧɢɤɚɥɶɧɨ, ɩɨɷɬɨɦɭ ɦɧɨɝɢɟ ɩɚɬɨɥɨɝɢɱɟɫɤɢɟ
ɫɨɫɬɨɹɧɢɹ ɩɪɨɬɟɤɚɸɬ ɧɢɜɟɥɢɪɨɜɚɧɨ.(1,4,5) Ɉɞɧɚɤɨ, ɜɨɡɞɟɣɫɬɜɢɟ ɧɟɤɨɬɨɪɵɯ ɮɚɤɬɨɪɨɜ ɩɪɟɜɵɲɚɟɬ
ɜɨɡɦɨɠɧɨɫɬɢ ɫɨɩɪɨɬɢɜɥɟɧɢɹ ɋɈɉɊ.(3,4) Ʉ ɫɨɠɚɥɟɧɢɸ, ɢ ɩɨ ɧɚɫɬɨɹɳɟɟ ɜɪɟɦɹ ɚɞɚɩɬɚɰɢɨɧɧɵɟ
ɜɨɡɦɨɠɧɨɫɬɢ ɋɈɉɊ ɟɳɟ ɦɚɥɨ ɢɡɭɱɟɧɵ, ɧɟɫɦɨɬɪɹ
ɧɚ ɧɨɜɵɟ ɩɨɞɯɨɞɵ ɞɢɚɝɧɨɫɬɢɤɢ, ɩɪɨɝɪɟɫɫɢɜɧɵɟ
ɬɟɯɧɨɥɨɝɢɢ ɢɡɭɱɟɧɢɹ.
Ⱦɚɧɧɨɟ ɩɨɥɨɠɟɧɢɟ ɨɛɨɫɧɨɜɚɧɨ ɬɟɦ, ɱɬɨ ɦɧɨɝɢɟ ɧɨɡɨɥɨɝɢɱɟɫɤɢɟ ɮɨɪɦɵ, ɩɪɨɹɜɥɹɸɳɢɟɫɹ ɜ
ɩɨɥɨɫɬɢ ɪɬɚ ɭ ɪɚɡɧɵɯ ɢɧɞɢɜɢɞɭɭɦɨɜ, ɩɪɨɬɟɤɚɸɬ
ɧɟɨɞɧɨɡɧɚɱɧɨ, ɱɬɨ ɨɛɶɹɫɧɹɟɬɫɹ ɩɨɥɢɦɨɪɮɢɡɦɨɦ
ɩɟɪɜɢɱɧɵɯ ɢ ɜɬɨɪɢɱɧɵɯ ɦɨɪɮɨɥɨɝɢɱɟɫɤɢɯ ɷɥɟɦɟɧɬɨɜ, ɚ ɬɚɤɠɟ ɩɪɢɫɨɟɞɢɧɟɧɢɟɦ ɜɬɨɪɢɱɧɨɣ
ɢɧɮɟɤɰɢɢ.(5)
Ɉɛɨɛɳɚɹ ɞɨɫɬɭɩɧɵɟ ɞɚɧɧɵɟ, ɡɚɛɨɥɟɜɚɧɢɹ
ɋɈɉɊ ɦɨɠɧɨ ɞɢɮɮɟɪɟɧɰɢɪɨɜɚɬɶ ɧɚ ɞɜɟ ɨɫɧɨɜɧɵɟ ɝɪɭɩɩɵ. ȼ ɩɟɪɜɭɸ ɝɪɭɩɩɭ ɜɯɨɞɹɬ ɩɚɬɨɥɨɝɢɱɟɫɤɢɟ ɩɪɨɰɟɫɫɵ, ɤɨɬɨɪɵɟ ɜɨɡɧɢɤɚɸɬ ɧɟɩɨɫɪɟɞɫɬɜɟɧɧɨ ɧɚ ɫɥɢɡɢɫɬɨɣ ɨɛɨɥɨɱɤɟ, ɜ ɪɟɡɭɥɶɬɚɬɟ
ɜɨɡɞɟɣɫɬɜɢɹ ɜɧɟɲɧɢɯ ɮɚɤɬɨɪɨɜ (ɬɪɚɜɦɚ, ɢɧɮɟɤɰɢɹ). ȼɬɨɪɭɸ ɝɪɭɩɩɭ ɩɪɟɞɫɬɚɜɥɹɸɬ ɡɚɛɨɥɟɜɚɧɢɹ,
ɧɚɫɬɭɩɚɸɳɢɟ ɜɫɥɟɞɫɬɜɢɟ ɧɚɪɭɲɟɧɢɣ ɮɭɧɤɰɢɣ
ɪɚɡɥɢɱɧɵɯ ɨɪɝɚɧɨɜ ɢ ɫɢɫɬɟɦ ɨɪɝɚɧɢɡɦɚ.
ɉɟɪɟɞ ɤɥɢɧɢɰɢɫɬɚɦɢ ɫɬɨɹɬ ɫɥɨɠɧɵɟ ɡɚɞɚɱɢ
ɞɢɮɮɟɪɟɧɰɢɚɰɢɢ, ɞɢɚɝɧɨɫɬɢɤɢ ɡɚɛɨɥɟɜɚɧɢɣ
ɋɈɉɊ, ɱɬɨ ɩɪɢ ɝɪɚɦɨɬɧɨɦ ɩɨɞɯɨɞɟ ɩɨɡɜɨɥɢɬ
ɪɟɲɢɬɶ ɜɨɩɪɨɫɵ ɭɫɩɟɲɧɨɣ ɬɟɪɚɩɢɢ ɫɨɨɬɜɟɬɫɬɜɭɸɳɟɣ ɩɚɬɨɥɨɝɢɢ. (2,6,7)
Ʉɨɧɟɱɧɨ ɠɟ, ɭɫɩɟɯ ɬɟɪɚɩɢɢ ɡɚɜɢɫɢɬ ɤɚɤ ɨɬ
ɢɫɩɨɥɶɡɨɜɚɧɢɹ ɞɢɚɝɧɨɫɬɢɱɟɫɤɢɯ ɦɟɬɨɞɢɤ, ɬɚɤ ɢ
ɩɪɟɞɥɚɝɚɟɦɵɯ ɩɪɢ ɷɬɨɦ ɫɨɜɪɟɦɟɧɧɵɯ ɩɪɟɩɚɪɚɬɨɜ. ɇɟɫɦɨɬɪɹ ɧɚ ɞɨɫɬɚɬɨɱɧɭɸ ɨɫɜɟɳɟɧɧɨɫɬɶ
ɷɬɨɝɨ ɜɨɩɪɨɫɚ ɜ ɫɩɟɰɢɚɥɶɧɨɣ ɥɢɬɟɪɚɬɭɪɟ,
ɩɪɨɛɥɟɦɚ ɲɢɪɨɤɨɝɨ ɜɧɟɞɪɟɧɢɹ ɜ ɩɨɥɢɤɥɢɧɢɱɟɫɤɭɸ ɩɪɚɤɬɢɤɭ ɧɨɜɵɯ ɦɚɬɟɪɢɚɥɨɜ, ɩɪɟɩɚɪɚɬɨɜ
ɟɳɟ ɧɟ ɪɟɲɟɧɚ, ɚ ɢɦɟɸɳɢɣɫɹ ɚɪɫɟɧɚɥ ɥɟɱɟɛɧɨɩɪɨɮɢɥɚɤɬɢɱɟɫɤɢɯ ɫɪɟɞɫɬɜ, ɢɫɩɨɥɶɡɭɟɦɵɯ ɩɪɢ
ɡɚɛɨɥɟɜɚɧɢɹɯ ɫɥɢɡɢɫɬɨɣ ɨɛɨɥɨɱɤɢ ɩɨɥɨɫɬɢ ɪɬɚ, ɜ
ɛɨɥɶɲɢɧɫɬɜɟ ɫɥɭɱɚɟɜ ɨɫɬɚɟɬɫɹ ɦɚɥɨɷɮɮɟɤɬɢɜɧɵɦ, ɜ ɫɜɹɡɢ ɫ ɱɟɦ ɜɟɞɟɬɫɹ ɩɨɫɬɨɹɧɧɵɣ ɩɨɢɫɤ
ɧɚɢɛɨɥɟɟ ɷɮɮɟɤɬɢɜɧɵɯ ɫɪɟɞɫɬɜ, ɧɚɩɪɚɜɥɟɧɧɵɯ
ɧɚ ɪɟɚɛɢɥɢɬɚɰɢɸ ɛɨɥɶɧɵɯ ɫ ɡɚɛɨɥɟɜɚɧɢɹɦɢ
ɋɈɉɊ. ȼɫɟ ɷɬɢ ɜɨɩɪɨɫɵ ɹɜɥɹɸɬɫɹ ɱɪɟɡɜɵɱɚɣɧɨ
ɚɤɬɭɚɥɶɧɵɦɢ ɢ ɢɯ ɪɟɲɟɧɢɟ ɧɟɫɨɦɧɟɧɧɨ ɛɭɞɟɬ
ɫɩɨɫɨɛɫɬɜɨɜɚɬɶ ɞɚɥɶɧɟɣɲɟɦɭ ɪɚɡɜɢɬɢɸ ɩɨɥɢɤɥɢɧɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ.
ɂɫɯɨɞɹ ɢɡ ɜɵɲɟɢɡɥɨɠɟɧɧɨɝɨ, ɦɵ ɫɱɢɬɚɟɦ
ɰɟɥɟɫɨɨɛɪɚɡɧɵɦ ɚɤɬɭɚɥɢɡɚɰɢɸ ɥɟɱɟɛɧɵɯ ɦɟɪɨɩɪɢɹɬɢɣ, ɧɚɩɪɚɜɥɟɧɧɵɯ ɧɚ ɤɭɩɢɪɨɜɚɧɢɟ ɪɚɡɥɢɱɧɨɝɨ ɪɨɞɚ ɜɨɫɩɚɥɢɬɟɥɶɧɵɯ ɩɪɨɰɟɫɫɨɜ ɫɥɢɡɢɫɬɨɣ
ɨɛɨɥɨɱɤɢ ɩɨɥɨɫɬɢ ɪɬɚ, ɨɫɭɳɟɫɬɜɥɹɹ ɫ ɩɨɡɢɰɢɣ
ɤɨɦɩɥɟɤɫɧɨɝɨ ɩɨɞɯɨɞɚ:
- ɪɚɡɪɚɛɨɬɤɚ ɫɪɟɞɫɬɜ ɧɟɩɨɫɪɟɞɫɬɜɟɧɧɨɝɨ ɢɥɢ
ɢɧɨɝɨ ɜɨɡɞɟɣɫɬɜɢɹ,
40
- ɫɨɡɞɚɧɢɟ ɜ ɨɛɥɚɫɬɢ ɜɨɡɞɟɣɫɬɜɢɹ ɨɩɬɢɦɚɥɶɧɵɯ
ɭɫɥɨɜɢɣ ɞɥɹ ɷɥɢɦɢɧɢɪɨɜɚɧɢɹ ɜɨɫɩɚɥɢɬɟɥɶɧɨɝɨ
ɩɪɨɰɟɫɫɚ ɢ ɜɨɫɫɬɚɧɨɜɥɟɧɢɹ ɬɤɚɧɟɜɵɯ ɷɥɟɦɟɧɬɨɜ,
- ɩɪɨɮɢɥɚɤɬɢɤɚ ɜɨɡɦɨɠɧɵɯ ɨɫɥɨɠɧɟɧɢɣ.
ȼ ɫɜɹɡɢ ɫ ɷɬɢɦ, ɧɚɦɢ ɛɵɥɚ ɩɪɟɞɥɨɠɟɧɚ
ɚɩɪɨɛɚɰɢɹ ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ ɜ ɤɥɢɧɢɤɚɯ
ɬɟɪɚɩɟɜɬɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ ȿɪȽɆɍ ɢɦ.
Ɇ.Ƚɟɪɚɰɢ ɩɪɢ ɧɚɢɛɨɥɟɟ ɪɚɫɩɪɨɫɬɪɚɧɟɧɧɵɯ
ɡɚɛɨɥɟɜɚɧɢɹɯ ɫɥɢɡɢɫɬɨɣ ɨɛɨɥɨɱɤɢ ɩɨɥɨɫɬɢ ɪɬɚ.
ɐɟɥɶ ɢɫɫɥɟɞɨɜɚɧɢɹ: Ⱥɩɪɨɛɚɰɢɹ ɩɪɟɩɚɪɚɬɚ
“Ɍɚɧɬɭɦ ȼɟɪɞɟ” ɜ ɞɢɧɚɦɢɤɟ ɥɟɱɟɧɢɹ ɨɫɧɨɜɧɵɯ
ɫɬɨɦɚɬɨɥɨɝɢɱɟɫɤɢɯ ɡɚɛɨɥɟɜɚɧɢɣ.
Ɍɚɧɬɭɦ ȼɟɪɞɟ ɹɜɥɹɟɬɫɹ ɧɟɫɬɟɪɨɢɞɧɵɦ ɩɪɨɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɵɦ ɩɪɟɩɚɪɚɬɨɦ, ɩɪɢɧɚɞɥɟɠɢɬ ɤ
ɝɪɭɩɩɟ ɢɧɞɚɡɨɥɨɜ. Ɉɤɚɡɵɜɚɟɬ ɦɟɫɬɧɨɟ ɚɧɟɫɬɟɡɢɪɭɸɳɟɟ ɞɟɣɫɬɜɢɟ, ɨɛɥɚɞɚɟɬ ɚɧɬɢɫɟɩɬɢɱɟɫɤɢɦ
ɞɟɣɫɬɜɢɟɦ . Ɇɟɯɚɧɢɡɦ ɞɟɣɫɬɜɢɹ ɩɪɟɩɚɪɚɬɚ, ɜ
ɨɬɥɢɱɢɟ ɨɬ ɨɛɵɱɧɵɯ ɇɉȼɉ, ɩɪɨɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɚɹ ɚɤɬɢɜɧɨɫɬɶ ɤɨɬɨɪɵɯ ɫɜɹɡɚɧɚ ɫ ɩɨɞɚɜɥɟɧɢɟɦ ɫɢɧɬɟɡɚ ɩɪɨɫɬɚɝɥɚɧɞɢɧɨɜ, ɧɚɩɪɚɜɥɟɧ ɧɚ
ɩɨɞɚɜɥɟɧɢɟ ɫɢɧɬɟɡɚ ɩɪɨɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɵɯ
ɰɢɬɨɤɢɧɨɜ.
Ȼɟɧɡɢɞɚɦɢɧ ɨɤɚɡɵɜɚɟɬ ɚɧɬɢɛɚɤɬɟɪɢɚɥɶɧɨɟ
ɞɟɣɫɬɜɢɟ ɢ ɫɩɟɰɢɮɢɱɟɫɤɨɟ ɚɧɬɢɦɢɤɪɨɛɧɨɟ
ɞɟɣɫɬɜɢɟ ɡɚ ɫɱɟɬ ɛɵɫɬɪɨɝɨ ɩɪɨɧɢɤɧɨɜɟɧɢɹ ɱɟɪɟɡ
ɦɟɦɛɪɚɧɵ ɦɢɤɪɨɨɪɝɚɧɢɡɦɨɜ, ɫ ɩɨɫɥɟɞɭɸɳɢɦ
ɩɨɜɪɟɠɞɟɧɢɟɦ ɤɥɟɬɨɱɧɵɯ ɫɬɪɭɤɬɭɪ, ɧɚɪɭɲɟɧɢɟɦ
ɦɟɬɚɛɨɥɢɱɟɫɤɢɯ ɩɪɨɰɟɫɫɨɜ ɢ ɥɢɡɨɫɨɦ ɤɥɟɬɨɤ.
ɉɪɨɬɢɜɨɝɪɢɛɤɨɜɨɟ ɞɟɣɫɬɜɢɟ ɜ ɨɬɧɨɲɟɧɢɢ Candida Albicans ɨɫɭɳɟɫɬɜɥɹɟɬɫɹ ɡɚ ɫɱɟɬ ɫɬɪɭɤɬɭɪɧɵɯ
ɦɨɞɢɮɢɤɚɰɢɣ ɤɥɟɬɨɱɧɨɣ ɫɬɟɧɤɢ ɝɪɢɛɨɜ ɢ
ɦɟɬɚɛɨɥɢɱɟɫɤɢɯ ɰɟɩɟɣ ɦɢɰɟɬɨɜ, ɩɪɟɩɹɬɫɬɜɭɹ ɢɯ
ɪɟɩɪɨɞɭɤɰɢɢ, ɱɬɨ ɹɜɥɹɟɬɫɹ ɨɫɧɨɜɚɧɢɟɦ ɞɥɹ
ɩɪɢɦɟɧɟɧɢɹ ɛɟɧɡɢɞɚɦɢɧɚ ɩɪɢ ɜɨɫɩɚɥɢɬɟɥɶɧɵɯ
ɩɪɨɰɟɫɫɚɯ ɪɨɬɨɜɨɣ ɩɨɥɨɫɬɢ, ɜɤɥɸɱɚɹ ɢɧɮɟɤɰɢɨɧɧɭɸ (ɫɦ. ɢɧɫɬɪɭɤɰɢɸ ɩɨ ɦɟɞɢɰɢɧɫɤɨɦɭ
ɩɪɢɦɟɧɟɧɢɸ ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ).
ɉɪɟɩɚɪɚɬ ɩɪɨɢɡɜɨɞɢɬɫɹ ɢɬɚɥɶɹɧɫɤɨɣ ɤɨɦɩɚɧɢɟɣ «Ⱥɡɢɟɧɞɟ Ʉɢɦɢɤɟ Ɋɢɭɧɢɬɟ Ⱥɧɞɠɟɥɢɧɢ
Ɏɪɚɧɱɟɫɤɨ Ⱥ.Ʉ.Ɋ.Ⱥ.Ɏ. ɋ.ɩ.Ⱥ.», Ɋɢɦ, ɂɬɚɥɢɹ.
ȼɵɲɟɭɤɚɡɚɧɧɵɟ ɫɜɨɣɫɬɜɚ ɩɪɟɩɚɪɚɬɚ ɩɨɫɥɭɠɢɥɢ ɨɫɧɨɜɚɧɢɟɦ ɞɥɹ ɟɝɨ ɢɧɬɟɪɩɨɥɢɪɨɜɚɧɢɹ ɜ
ɤɥɢɧɢɤɚɯ ɬɟɪɚɩɟɜɬɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ ȿɪȽɆɍ
ɩɪɢ ɧɚɢɛɨɥɟɟ ɲɢɪɨɤɨ ɪɚɫɩɪɨɫɬɪɚɧɟɧɧɵɯ ɡɚɛɨɥɟɜɚɧɢɹɯ ɫɥɢɡɢɫɬɨɣ ɨɛɨɥɨɱɤɢ ɩɨɥɨɫɬɢ ɪɬɚ, ɫ
ɩɨɫɥɟɞɭɸɳɟɣ ɨɰɟɧɤɨɣ ɷɮɮɟɤɬɢɜɧɨɫɬɢ ɢɫɩɨɥɶɡɭɟɦɨɝɨ ɩɪɟɩɚɪɚɬɚ.
Ɇɚɬɟɪɢɚɥ ɢ ɦɟɬɨɞɵ ɢɫɫɥɟɞɨɜɚɧɢɣ.
ɉɪɟɩɚɪɚɬ ɢɫɩɨɥɶɡɨɜɚɥɫɹ ɫɬɪɨɝɨ ɩɨ ɢɧɫɬɪɭɤɰɢɢ, ɜ ɜɢɞɟ ɬɚɛɥɟɬɨɤ, ɩɨɥɨɫɤɚɧɢɣ ɢ ɫɩɪɟɹ.
ȼ ɨɫɧɨɜɧɭɸ ɝɪɭɩɩɭ ɧɚɛɥɸɞɟɧɢɣ ɢ ɝɪɭɩɩɭ
ɫɪɚɜɧɟɧɢɣ ɜɤɥɸɱɟɧɵ ɛɨɥɶɧɵɟ ɩɨ ɜɨɡɪɚɫɬɭ (ɨɬ 16
ɥɟɬ ɢ ɫɬɚɪɲɟ) ɢ ɩɨ ɩɨɥɭ (ɫɦ.ɬɚɛɥ.1).
ȼɵɛɨɪ ɩɪɟɩɚɪɚɬɚ ɫɨɝɥɚɫɨɜɚɥɫɹ ɫ ɩɚɰɢɟɧɬɚɦɢ,
ɭɱɢɬɵɜɚɹ ɩɨɤɚɡɚɧɢɹ ɢ ɩɪɨɬɢɜɨɩɨɤɚɡɚɧɢɹ, ɚ ɬɚɤɠɟ ɤɥɢɧɢɱɟɫɤɨɟ ɬɟɱɟɧɢɟ ɫɨɨɬɜɟɬɫɬɜɭɸɳɟɣ ɧɨɡɨɥɨɝɢɱɟɫɤɨɣ ɟɞɢɧɢɰɵ (ɬɚɛɥ. 2), ɫɨɫɬɨɹɧɢɟ ɜɧɭɬ-
ɪɟɧɧɢɯ ɨɪɝɚɧɨɜ ɢ ɫɢɫɬɟɦ, ɩɨ ɧɟɨɛɯɨɞɢɦɨɫɬɢ ɩɪɨɜɨɞɢɥɢɫɶ ɤɨɧɫɭɥɶɬɚɰɢɢ ɫɨ ɫɦɟɠɧɵɦɢ ɫɩɟɰɢɚɥɢɫɬɚɦɢ.
Ȼɨɥɶɧɵɦ ɨɫɧɨɜɧɨɣ ɝɪɭɩɩɵ ɢ ɝɪɭɩɩɵ ɫɪɚɜɧɟɧɢɹ ɩɪɨɜɨɞɢɥɨɫɶ ɪɟɧɬɝɟɧɨɥɨɝɢɱɟɫɤɨɟ ɢɫɫɥɟɞɨɜɚɧɢɟ (ɜɧɭɬɪɢɪɨɬɨɜɵɟ ɩɪɢɰɟɥɶɧɵɟ ɫɧɢɦɤɢ, ɨɪɬɨɩɚɧɬɨɦɨɝɪɚɮɢɹ), ɚ ɬɚɤɠɟ ɦɢɤɪɨɛɢɨɥɨɝɢɱɟɫɤɢɣ
ɚɧɚɥɢɡ ɩɨ ɦɟɬɨɞɢɤɟ Ɂɢɧɨɜɶɟɜɨɣ-Ʉɚɝɪɚɦɚɧɨɜɨɣ,
ɝɞɟ ɢɞɟɧɬɢɮɢɰɢɪɨɜɚɥɢɫɶ ɤɨɥɢɱɟɫɬɜɟɧɧɵɟ ɢ
ɤɚɱɟɫɬɜɟɧɧɵɟ ɯɚɪɚɤɬɟɪɢɫɬɢɤɢ ɨɛɧɚɪɭɠɟɧɧɵɯ
ɦɢɤɪɨɛɨɜ, ɛɚɤɬɟɪɢɣ ɢ ɢɯ ɩɪɨɞɭɤɰɢɣ, ɝɪɢɛɤɨɜɵɯ
ɩɨɪɚɠɟɧɢɣ, ɨɩɪɟɞɟɥɹɥɚɫɶ ɱɭɜɫɬɜɢɬɟɥɶɧɨɫɬɶ ɤ
ɚɧɬɢɛɢɨɬɢɤɚɦ.
Ɇɟɬɨɞɢɤɚ ɡɚɤɥɸɱɚɟɬɫɹ ɜ ɫɥɟɞɭɸɳɟɦ: ɛɨɥɶɧɵɦ ɪɟɤɨɦɟɧɞɭɟɬɫɹ ɱɢɫɬɤɚ ɡɭɛɨɜ ɧɚ ɧɨɱɶ ɩɨɫɥɟ
ɩɪɢɧɹɬɢɹ ɩɢɳɢ ɢ ɭɩɨɬɪɟɛɥɟɧɢɹ ɠɢɞɤɨɫɬɟɣ. Ⱦɥɹ
ɩɨɥɭɱɟɧɢɹ ɧɚɬɢɜɧɨɣ ɤɚɪɬɢɧɵ ɛɟɪɭɬɫɹ ɚɧɚɥɢɡɵ
ɞɥɹ ɛɚɤɬɟɪɢɨɥɨɝɢɱɟɫɤɢɯ ɢɫɫɥɟɞɨɜɚɧɢɣ ɫɥɟɞɭɸɳɢɦ ɨɛɪɚɡɨɦ: ɜɚɬɧɵɟ ɬɭɪɭɧɞɵ ɧɚ ɤɨɪɧɟɜɨɣ
ɢɝɥɟ, ɭɤɥɚɞɵɜɚɸɬɫɹ ɜ ɡɭɛɨɞɟɫɧɟɜɵɟ ɤɚɪɦɚɧɵ ɜ
ɪɚɡɧɵɯ ɬɨɩɨɝɪɚɮɢɱɟɫɤɢɯ ɡɨɧɚɯ ɪɨɬɨɜɨɣ ɩɨɥɨɫɬɢ. Ȼɨɥɶɧɵɦ ɪɟɤɨɦɟɧɞɭɟɬɫɹ ɩɨɫɥɟ ɭɥɨɠɟɧɢɹ
ɬɭɪɭɧɞ ɩɚɥɶɰɟɜɨɟ ɦɚɫɫɢɪɨɜɚɧɢɟ ɳɟɤ ɢ ɝɭɛ ɜ
ɬɟɱɟɧɢɟ 5-10 ɦɢɧɭɬ, ɫ ɰɟɥɶɸ ɢɦɩɪɟɝɧɚɰɢɢ ɫɨɞɟɪɠɢɦɨɝɨ ɡɭɛɨɞɟɫɧɟɜɨɝɨ ɤɚɪɦɚɧɚ ɜ ɭɥɨɠɟɧɧɵɟ
ɜɚɬɧɵɟ ɬɭɪɭɧɞɵ. Ⱦɚɥɟɟ, ɫ ɪɚɡɥɢɱɧɵɯ ɬɨɩɨɝɪɚɮɢɱɟɫɤɢɯ ɡɨɧ ɫɥɢɡɢɫɬɨɣ ɨɛɨɥɨɱɤɢ ɪɨɬɨɜɨɣ
ɩɨɥɨɫɬɢ, ɜɤɥɸɱɚɹ ɤɨɪɟɧɶ ɹɡɵɤɚ, ɭɝɥɵ ɪɬɚ, ɫɬɟɪɢɥɶɧɵɦ ɜɚɬɧɵɦ ɲɩɚɬɟɥɟɦ ɛɟɪɟɬɫɹ ɫɦɵɜ, ɭɞɚɥɹɸɬɫɹ ɭɥɨɠɟɧɧɵɟ ɜɚɬɧɵɟ ɬɭɪɭɧɞɵ ɢɡ ɡɭɛɨɞɟɫɧɟɜɵɯ ɤɚɪɦɚɧɨɜ ɜ ɫɬɟɪɢɥɶɧɭɸ ɩɪɨɛɢɪɤɭ ɢ, ɜ
ɬɟɱɟɧɢɟ 30-60 ɦɢɧɭɬ, ɩɨɥɭɱɟɧɧɵɣ
ɦɚɬɟɪɢɚɥ
ɨɬɩɪɚɜɥɹɟɬɫɹ ɜ ɛɚɤɬɟɪɢɨɥɨɝɢɱɟɫɤɭɸ ɥɚɛɨɪɚɬɨɪɢɸ, ɝɞɟ ɨɩɪɟɞɟɥɹɸɬɫɹ ɤɚɱɟɫɬɜɟɧɧɵɟ ɢ ɤɨɥɢɱɟɫɬɜɟɧɧɵɟ ɩɨɤɚɡɚɬɟɥɢ ɦɢɤɪɨɮɥɨɪɵ, ɱɭɜɫɬɜɢɬɟɥɶɧɨɫɬɶ ɤ ɚɧɬɢɛɢɨɬɢɤɚɦ ɢ ɝɪɢɛɤɨɜɵɦ ɩɨɪɚɠɟɧɢɹɦ.
ɍ ɛɨɥɶɧɵɯ ɫ ɜɵɹɜɥɟɧɧɨɣ ɩɚɬɨɥɨɝɢɟɣ ɩɚɪɨɞɨɧɬɚ ɛɵɥɢ ɢɫɩɨɥɶɡɨɜɚɧɵ ɢɧɞɟɤɫɧɵɟ ɩɨɤɚɡɚɬɟɥɢ
PMA ɢ PI, ɩɪɟɞɥɨɠɟɧɧɵɟ Russel ɜ ɦɨɞɢɮɢɤɚɰɢɢ
Parma. Ƚɢɝɢɟɧɢɱɟɫɤɨɟ ɫɨɫɬɨɹɧɢɟ ɩɨɥɨɫɬɢ ɪɬɚ
ɨɰɟɧɢɜɚɥɨɫɶ ɩɨ ɢɧɞɟɤɫɭ (ɂȽ) Ɏɟɞɨɪɨɜɚ-ȼɨɥɨɞɤɢɧɨɣ ɢ ɭɩɪɨɳɟɧɧɨɦɭ ɢɧɞɟɤɫɭ ɝɢɝɢɟɧɵ (ɂȽɊ-ɇ)
Green-Vermillion, ɤɨɬɨɪɵɣ ɩɪɟɞɫɬɚɜɥɹɟɬ ɫɭɦɦɭ
ɡɧɚɱɟɧɢɣ ɢɧɞɟɤɫɚ ɡɭɛɧɨɝɨ ɧɚɥɟɬɚ (OHI-S).
Ƚɥɭɛɢɧɭ ɩɚɪɨɞɨɧɬɚɥɶɧɵɯ ɤɚɪɦɚɧɨɜ ɢɡɦɟɪɹɥɢ
ɫ ɩɨɦɨɳɶɸ ɝɪɚɞɭɢɪɨɜɚɧɧɨɝɨ ɡɨɧɞɚ, ɩɪɟɞɜɚɪɢɬɟɥɶɧɨ ɨɛɟɡɛɨɥɢɜɚɹ ɞɚɧɧɵɣ ɫɟɝɦɟɧɬ ɩɪɟɞɥɚɝɚɟɦɵɦ ɩɪɟɩɚɪɚɬɨɦ (Ɍɚɧɬɭɦ ȼɟɪɞɟ ɜ ɜɢɞɟ
ɫɩɪɟɹ).
Ⱦɨ ɧɚɡɧɚɱɟɧɢɹ ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ, ɩɪɢ
ɜɵɹɜɥɟɧɧɨɣ ɩɚɬɨɥɨɝɢɢ ɩɚɪɨɞɨɧɬɚ, ɛɵɥɚ ɩɪɨɜɟɞɟɧɚ ɫɨɨɬɜɟɬɫɬɜɭɸɳɚɹ ɫɬɚɧɞɚɪɬɧɚɹ ɬɟɪɚɩɢɹ:
ɨɩɪɟɞɟɥɟɧɢɟ ɜ ɞɢɧɚɦɢɤɟ ɢɧɞɟɤɫɧɵɯ ɩɨɤɚɡɚɬɟɥɟɣ,
ɭɞɚɥɟɧɢɟ ɧɚɞ- ɢ ɩɨɞɞɟɫɧɟɜɵɯ ɨɬɥɨɠɟɧɢɣ, ɧɚɡɧɚɱɟɧɢɟ ɜ ɜɢɞɟ ɚɩɩɥɢɤɚɰɢɣ ɜ ɩɚɬɨɥɨɝɢɱɟɫɤɢɟ ɡɭɛɨ-
ɞɟɫɧɟɜɵɟ ɤɚɪɦɚɧɵ ɩɪɟɩɚɪɚɬɨɜ, ɫ ɭɱɟɬɨɦ ɜɵɹɜɥɟɧɧɨɣ ɱɭɜɫɬɜɢɬɟɥɶɧɨɫɬɢ ɤ ɚɧɬɢɛɢɨɬɢɤɚɦ ɢ
ɬɹɠɟɫɬɢ ɤɥɢɧɢɱɟɫɤɨɝɨ ɬɟɱɟɧɢɹ. Ȼɨɥɶɧɵɦ ɫ
ɜɢɪɭɫɧɵɦɢ (ɩɨɞ ɧɚɛɥɸɞɟɧɢɟɦ ɧɚɯɨɞɢɥɢɫɶ
ɬɨɥɶɤɨ ɛɨɥɶɧɵɟ ɫ Herpes simplex) ɢ ɝɪɢɛɤɨɜɵɦɢ
ɩɨɪɚɠɟɧɢɹɦɢ (Candida albicans), ɩɪɟɩɚɪɚɬ ɧɚɡɧɚɱɚɥɫɹ ɜ ɤɨɦɩɥɟɤɫɧɨɣ ɬɟɪɚɩɢɢ, ɭɱɢɬɵɜɚɹ ɫɬɚɞɢɣɧɨɫɬɶ ɷɬɚɩɨɜ ɬɟɱɟɧɢɹ ɨɫɧɨɜɧɨɣ ɩɚɬɨɥɨɝɢɢ, ɬ.
ɟ. ɜ ɫɨɱɟɬɚɧɢɢ ɫ ɩɪɨɬɢɜɨɜɢɪɭɫɧɵɦɢ ɢ ɩɪɨɬɢɜɨɝɪɢɛɤɨɜɵɦɢ ɩɪɟɩɚɪɚɬɚɦɢ.
Ɉɛɫɭɠɞɟɧɢɟ ɩɨɥɭɱɟɧɧɵɯ ɪɟɡɭɥɶɬɚɬɨɜ.
Ⱥɧɚɥɢɡɢɪɭɹ ɤɥɢɧɢɱɟɫɤɢɟ ɧɚɛɥɸɞɟɧɢɹ ɛɨɥɶɧɵɯ ɨɫɧɨɜɧɨɣ ɝɪɭɩɩɵ, ɫ ɭɱɟɬɨɦ ɩɨɥɨɜɵɯ ɪɚɡɥɢɱɢɣ, ɜɨɡɪɚɫɬɚ ɢ ɧɨɡɨɥɨɝɢɱɟɫɤɨɣ ɟɞɢɧɢɰɵ (ɬɚɜɥ.
1,2), ɛɵɥɨ ɜɵɹɜɥɟɧɨ, ɱɬɨ ɫɬɨɦɚɬɨɥɨɝɢɱɟɫɤɢɣ
ɫɬɚɬɭɫ ɢɦɟɟɬ ɩɨɥɨɠɢɬɟɥɶɧɵɟ ɫɞɜɢɝɢ ɩɨ ɨɬɧɨɲɟɧɢɸ ɤ ɝɪɭɩɩɟ ɫɪɚɜɧɟɧɢɹ, ɜ ɛɨɥɟɟ ɭɤɨɪɨɱɟɧɧɵɟ
ɫɪɨɤɢ.
ɂɡ 53 ɛɨɥɶɧɵɯ ɨɫɧɨɜɧɨɣ ɝɪɭɩɩɵ ɧɚɛɥɸɞɟɧɢɣ, 35-ɢ ɛɨɥɶɧɵɦ ɫ ɩɚɬɨɥɨɝɢɟɣ ɩɚɪɨɞɨɧɬɚ ɢ
ɫɬɨɦɚɬɢɬɚɦɢ, ɛɵɥɨ ɧɚɡɧɚɱɟɧɨ ɩɪɢɦɟɧɟɧɢɟ ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ, ɨɞɧɨɜɪɟɦɟɧɧɨ ɤɚɤ ɜ ɜɢɞɟ
ɩɨɥɨɫɤɚɧɢɣ, ɬɚɤ ɢ ɜ ɜɢɞɟ ɬɚɛɥɟɬɨɤ ɞɥɹ ɪɚɫɫɚɫɵɜɚɧɢɹ, ɫɬɪɨɝɨ ɫ ɭɱɟɬɨɦ ɢɧɫɬɪɭɤɰɢɢ ɩɨ
ɩɪɢɦɟɧɟɧɢɸ.
ɍɥɭɱɲɟɧɢɟ ɫɪɟɞɧɢɯ ɩɚɪɨɞɨɧɬɚɥɶɧɵɯ ɢ ɝɢɝɢɟɧɢɱɟɫɤɢɯ ɢɧɞɟɤɫɧɵɯ ɩɨɤɚɡɚɬɟɥɟɣ ɨɫɧɨɜɧɨɣ
ɝɪɭɩɩɵ, ɩɨ ɨɬɧɨɲɟɧɢɸ ɤ ɝɪɭɩɩɟ ɛɨɥɶɧɵɯ, ɧɚɯɨɞɹɳɢɯɫɹ ɜ ɝɪɭɩɩɟ ɫɪɚɜɧɟɧɢɹ, ɩɨɥɭɱɚɜɲɢɯ ɩɚɬɨɝɟɧɟɬɢɱɟɫɤɭɸ ɬɪɚɞɢɰɢɨɧɧɭɸ ɬɟɪɚɩɢɸ, ɝɨɜɨɪɢɬ ɨ
ɧɟɫɨɦɧɟɧɧɨɦ ɩɪɟɢɦɭɳɟɫɬɜɟ ɢɫɩɨɥɶɡɭɟɦɨɝɨ
ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ. Ⱦɚɧɧɵɣ ɜɵɜɨɞ ɨɫɧɨɜɚɧ
ɧɚ ɫɥɟɞɭɸɳɢɯ ɩɨɤɚɡɚɬɟɥɹɯ:
ɍɦɟɧɶɲɟɧɢɟ ɢ ɢɫɱɟɡɧɨɜɟɧɢɟ ɤɪɨɜɨɬɨɱɢɜɨɫɬɢ
ɢɡ ɞɟɫɟɧ ɩɪɢ ɡɚɛɨɥɟɜɚɧɢɹɯ ɬɤɚɧɟɣ ɩɚɪɨɞɨɧɬɚ,
ɨɬɫɭɬɫɬɜɢɟ ɡɚɩɚɯɚ ɢɡ ɩɨɥɨɫɬɢ ɪɬɚ (Foeter ex ore).
ɍɫɤɨɪɟɧɧɵɟ ɫɪɨɤɢ ɡɚɠɢɜɥɟɧɢɹ ɢ ɷɩɢɬɟɥɢɡɚɰɢɢ
ɩɪɢ ɜɢɪɭɫɧɵɯ ɢ ɝɪɢɛɤɨɜɵɯ ɩɨɪɚɠɟɧɢɹɯ ɭ ɛɨɥɶɧɵɯ ɜ ɨɫɧɨɜɧɨɣ ɝɪɭɩɩɟ ɧɚɛɥɸɞɟɧɢɣ ɩɨ ɨɬɧɨɲɟɧɢɸ ɤ ɝɪɭɩɩɟ ɫɪɚɜɧɟɧɢɹ, ɦɨɠɧɨ ɫɜɹɡɚɬɶ ɫ
ɷɮɮɟɤɬɢɜɧɵɦ ɩɪɨɬɢɜɨɜɨɫɩɚɥɢɬɟɥɶɧɵɦ ɢ ɨɛɟɡɛɨɥɢɜɚɸɳɢɦ ɞɟɣɫɬɜɢɟɦ ɢɫɩɨɥɶɡɭɟɦɨɝɨ ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ, ɫ ɜɵɫɨɤɨɢɧɞɭɤɬɢɜɧɵɦɢ
ɫɜɨɣɫɬɜɚɦɢ ɢɧɢɰɢɚɥɶɧɨɝɨ ɤɨɦɩɨɧɟɧɬɚ ɩɪɟɩɚɪɚɬɚ
ȻȿɇɁɂȾȺɆɂɇ ȽɂȾɊɈɏɅɈɊɂȾ ɢ ɟɝɨ ɜɨɡɞɟɣɫɬɜɢɟɦ ɧɚ ɤɥɟɬɨɱɧɵɟ ɫɬɪɭɤɬɭɪɵ, ɢ ɚɛɨɪɬɚɰɢɟɣ ɦɢɬɨɡɧɨɣ ɚɤɬɢɜɧɨɫɬɢ ɩɚɬɨɝɟɧɧɵɯ ɤɥɟɬɨɤ
ɜ ɷɩɢɬɟɥɢɚɥɶɧɵɯ ɬɤɚɧɹɯ.
ɉɨɥɭɱɟɧɧɵɟ ɩɨɥɨɠɢɬɟɥɶɧɵɟ ɤɥɢɧɢɱɟɫɤɢɟ
ɞɚɧɧɵɟ, ɨɬɫɭɬɫɬɜɢɟ ɩɨɛɨɱɧɵɯ ɷɮɮɟɤɬɨɜ ɩɪɢ ɩɪɢɦɟɧɟɧɢɢ ɜ ɤɥɢɧɢɤɟ ɬɟɪɚɩɟɜɬɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ ɩɪɢ ɜɵɲɟɭɤɚɡɚɧɧɵɯ ɩɚɬɨɥɨɝɢɹɯ ɋɈɉɊ,
ɹɜɥɹɸɬɫɹ ɨɫɧɨɜɚɧɢɟɦ ɞɥɹ ɪɟɤɨɦɟɧɞɚɰɢɢ ɩɪɟɩɚɪɚɬɚ Ɍɚɧɬɭɦ ȼɟɪɞɟ ɞɥɹ ɲɢɪɨɤɨɝɨ ɢɫɩɨɥɶɡɨɜɚɧɢɹ ɜ ɩɨɥɢɤɥɢɧɢɱɟɫɤɨɣ ɩɪɚɤɬɢɤɟ.
41
Ɋɚɫɩɪɟɞɟɥɟɧɢɟ ɛɨɥɶɧɵɯ, ɩɨɥɭɱɚɜɲɢɯ ɩɪɟɩɚɪɚɬ Ɍɚɧɬɭɦ ȼɟɪɞɟ, ɩɨ ɜɨɡɪɚɫɬɭ ɢ ɩɨɥɭ. (ɬɚɛɥ.1)
ȼɈɁɊȺɋɌ
ɉɈɅ
Ƚɪɭɩɩɚ ɧɚɛɥɸɞɟɧɢɣ
Ʉɨɥɢɱɟɫɬɜɨ
Ɇ
ɀ
Ɉɫɧɨɜɧɚɹ
ɋɪɚɜɧɢɬɟɥɶ
ɧɚɹ
5
4
16 – 21
9
6
3
22 – 30
17
12
5
14
3
31 – 45
20
11
9
15
5
46 – 55
17
8
9
12
5
56 ɢ ɜɵɲɟ
8
4
4
6
2
ɂɬɨɝɨ:
71
40
31
53
18
Ɋɚɫɩɪɟɞɟɥɟɧɢɟ ɛɨɥɶɧɵɯ, ɩɨɥɭɱɚɜɲɢɯ ɩɪɟɩɚɪɚɬ Ɍɚɧɬɭɦ ȼɟɪɞɟ, ɩɨ ɧɨɡɨɥɨɝɢɱɟɫɤɢɦ ɝɪɭɩɩɚɦ.(ɬɚɛɥ.2)
ɇɨɡɨɥɨɝɢɱɟɫɤɢɟ
Ɉɫɧɨɜɧɚɹ ɝɪɭɩɩɚ
Ƚɪɭɩɩɚ ɫɪɚɜɧɟɧɢɹ
ɂɬɨɝɨ
ɝɪɭɩɩɵ
Ƚɟɪɩɟɬɢɱɟɫɤɢɣ
6
3
9
ɫɬɨɦɚɬɢɬ
Ƚɪɢɛɤɨɜɵɟ ɩɨɪɚɠɟɧɢɹ
14
4
18
Ʌɨɤɚɥɢɡɨɜɚɧɧɚɹ ɮɨɪɦɚ 8
2
10
ɡɚɛɨɥɟɜɚɧɢɣ ɩɚɪɨɞɨɧɬɚ
7
3
10
Ƚɟɧɟɪɚɥɢɡɨɜɚɧɧɚɹ
ɮɨɪɦɚ
ɡɚɛɨɥɟɜɚɧɢɣ
ɩɚɪɨɞɨɧɬɚ
Ʉɚɬɚɪɚɥɶɧɵɣ ɫɬɨɦɚɬɢɬ
5
2
7
Ƚɢɩɟɪɬɪɨɮɢɱɟɫɤɢɣ
6
2
8
ɫɬɨɦɚɬɢɬ
Ƚɢɧɝɢɜɨɫɬɨɦɚɬɢɬ
7
2
9
ɂɬɨɝɨ:
53
18
71
Ʌɢɬɟɪɚɬɭɪɚ
1.
Ȼɚɪɟɪ Ƚ.Ɇ., Ʌɢɦɟɰɤɚɹ Ɍ. ɂ. – Ȼɨɥɟɡɧɢ
ɩɚɪɨɞɨɧɬɚ. Ʉɥɢɧɢɤɚ, ɞɢɚɝɧɨɫɬɢɤɚ, ɥɟɱɟɧɢɟ.
ɍɱɟɛɧɨɟ ɩɨɫɨɛɢɟ Ɇ. ȻɇɆɐ, 1996. c. 86
2.
Ⱥɧɞɪɢɚɫɹɧ Ʌ.Ƚ., Ⱥɜɟɬɢɫɹɧ Ⱥ.Ɂ., Ⱥɡɚɬɹɧ ɇ.Ƚ. –
ɂɧɞɟɤɫɧɚɹ ɨɰɟɧɤɚ ɥɟɱɟɧɢɹ ɩɚɪɨɞɨɧɬɢɬɨɜ. ɋɛɨɪɧɢɤ
ɧɚɭɱɧɵɯ ɬɪɭɞɨɜ ȿɪȽɆɍ ɢɦ. Ɇ. Ƚɟɪɚɰɢ 1997 ɬɨɦ 1, ɫ.
233-235
3.
Ʌɟɭɫ ɉ.Ⱥ. - Ʉɨɦɦɭɧɢɤɚɥɶɧɚɹ ɫɬɨɦɚɬɨɥɨɝɢɹ.
Ȼɪɟɫɬ , 2009, c. 284
4.
Ȼɭɞɵɥɢɧɚ ɋ.Ɇ., Ⱦɟɝɬɹɪɟɜ ȼ.ɉ. – Ɏɢɡɢɨɥɨɝɢɹ
ɱɟɥɸɫɬɧɨ-ɥɢɰɟɜɨɣ ɨɛɥɚɫɬɢ. Ɇ. Ɇɟɞɢɰɢɧɚ, 2001, c.350
5.
ɐɟɩɨɜ Ʌ.Ɇ. – Ɇɟɠɫɢɫɬɟɦɧɵɟ ɫɜɹɡɢ ɩɪɢ
ɛɨɥɟɡɧɹɯ ɩɚɪɨɞɨɧɬɚ. Ɇ. ɉɚɪɨɞɨɧɬɨɥɨɝɢɹ, 2003.N2,
c.19-24
6.
Ɇɟɥɟɧɛɟɪɝ Ɍ.ȼ. – Ⱥɧɚɥɢɡ ɨɛɪɚɳɚɟɦɨɫɬɢ
ɩɚɰɢɟɧɬɨɜ ɜ ɤɥɢɧɢɤɭ ɞɥɹ ɩɪɨɜɟɞɟɧɢɹ ɩɪɨɮɟɫɫɢɨɧɚɥɶɧɨɣ ɝɢɝɢɟɧɵ ɩɨɥɨɫɬɢ ɪɬɚ. Ɇɚɬɟɪɢɚɥɵ VII
ȼɫɟɪɨɫɫɢɣɫɤɨɝɨ ɧɚɭɱɧɨɝɨ ɮɨɪɭɦɚ. “ɋɬɨɦɚɬɨɥɨɝɢɹ
2005”.M.Ɇɟɞɢ ɗɤɫɩɨ. 2005, c.180-181
7.
Ʉɨɪɨɥɟɜ ɋ.Ʌ. – Ʉɥɢɧɢɤɨ-ɮɭɧɤɰɢɨɧɚɥɶɧɚɹ
ɯɚɪɚɤɬɟɪɢɫɬɢɤɚ ɩɚɬɨɥɨɝɢɱɟɫɤɢɯ ɫɨɫɬɨɹɧɢɣ ɩɚɪɨɞɨɧɬɚ
ɢ ɢɯ ɜɥɢɹɧɢɟ ɧɚ ɪɟɡɟɪɜɧɵɟ ɜɨɡɦɨɠɧɨɫɬɢ ɨɩɨɪɧɵɯ
ɡɭɛɨɜ. Ɇ. Ⱦɢɫɫ. ɤɚɧɞ. ɦɟɞ. ɧɚɭɤ.
42
Results of a clinical research of the drug Tantum
Verde in a therapeutic dentistry
Tatintsyan V.G
With a purpose of actualization of therapeutic
arrangements, directed to reduction of different types of
inflammatory processes of tunica mucosa of mouth,
approbation of the preparation Tantum Verde was offered
in clinics of preventive dentistry. The studies were made
in two groups of the patients – the main and comparative,
having applied the preparation Tantum Verde in the form
of spray, solution and tabs. Reduction and disappearance
of gingival hemorrhage at the diseases of parodentium
tissues, absence of offensive breath (Foeter ex ore),
healing up accelerated terms and epithelization at virus
and mycotic lesions at the patients in the main group of
the observations against the comparative group, we may
associate with effect of applied preparation Tantum
Verde with highly inductive properties of initial
component of preparation Benzidamine Hydrochloride
and its influence upon cellular constructions and abortion
of mitosic activity of pathogenic cells in epithelial tissues.
The received positive clinical data, absence of side effects
at application in preventive dentistry clinic at diseases of
tunica mucosa of mouth, are the grounds for
recommendation of the preparation Tantum Verde for
wide usage in polyclinic practice at main dental diseases.